NURS 6630 Approaches To Treatment Of
Psychopathology FINAL EXAM
Questions and Answers
QUESTION 1
What will the PMHNP most likely prescribe to a
... [Show More] patient with psychotic aggression who
needs to manage the top-down cortical control and the excessive drive from striatal
hyperactivity?
A. Stimulants B. Antidepressants C. Antipsychotics D. SSRIs
QUESTION 2
The PMHNP is selecting a medication treatment option for a patient who is exhibiting
psychotic behaviors with poor impulse control and aggression. Of the available
treatments, which can help temper some of the adverse effects or symptoms that are
normally caused by D2 antagonism?
A. First-generation, conventional antipsychotics B. First-generation, atypical
antipsychotics C. Second-generation, conventional antipsychotics D. Secondgeneration,
atypical antipsychotics
QUESTION 3
The PMHNP is discussing dopamine D2 receptor occupancy and its association with
aggressive behaviors in patients with the student. Why does the PMHNP prescribe a
standard dose of atypical antipsychotics?
A. The doses are based on achieving 100% D2 receptor occupancy. B. The doses are
based on achieving a minimum of 80% D2 receptor occupancy. C. The doses are
based on achieving 60% D2 receptor occupancy. D. None of the above.
QUESTION 4
Why does the PMHNP avoid prescribing clozapine (Clozaril) as a first-line treatment to
the patient with psychosis and aggression?
A. There is too high a risk of serious adverse side effects. B. It can exaggerate the
psychotic symptoms. C. Clozapine (Clozaril) should not be used as high-dose
monotherapy. D. There is no documentation that clozapine (Clozaril) is effective for
patients who are violent.
QUESTION 5
The PMHNP is caring for a patient on risperidone (Risperdal). Which action made by
the PMHNP exhibits proper care for this patient?
A. Explaining to the patient that there are no risks of EPS B. Prescribing the patient 12
mg/dail
C. Titrating the dose by increasing it every 5–7 days D. Writing a prescription for a
higher dose of oral risperidone (Risperdal) to achieve high D2 receptor occupancy
QUESTION 6
The PMHNP wants to prescribe Mr. Barber a mood stabilizer that will target aggressive
and impulsive symptoms by decreasing dopaminergic neurotransmission. Which mood
stabilizer will the PMHNP select? A. Lithium (Lithane) B. Phenytoin (Dilantin) C.
Valproate (Depakote) D. Topiramate (Topamax)
QUESTION 7
The parents of a 7-year-old patient with ADHD are concerned about the effects of
stimulants on their child. The parents prefer to start pharmacological treatment with a
non-stimulant. Which medication will the PMHNP will most likely prescribe?
A. Strattera B. Concerta C. Daytrana D.
Adderall QUESTION 8
8 The PMHNP understands that slow-dose extended release stimulants are most
appropriate for which patient with ADHD?
A. 8-year-old patient B. 24-year-old patient C. 55-year-old patient D. 82-year-old patient
QUESTION 9
A patient is prescribed D-methylphenidate, 10-mg extended-release capsules. What
should the PMHNP include when discussing the side effects with the patient?
A. The formulation can have delayed actions when taken with food. B. Sedation can be
a common side effect of the drug. C. The medication can affect your blood pressure.
D. This drug does not cause any dependency.
QUESTION 10
The PMHNP is teaching parents about their child’s new prescription for Ritalin. What
will the PMHNP include in the teaching?
A. The second dose should be taken at lunch. B. There are no risks for insomnia. C.
There is only one daily dose, to be taken in the morning. D. There will be continued
effects into the evening.
QUESTION 11
A young patient is prescribed Vyvanse. During the follow-up appointment, which
comment made by the patient makes the PMHNP think that the dosing is being done
incorrectly?
A. “I take my pill at breakfast.” B. “I am unable to fall asleep at night.” C. “I feel okay
all day long.” D. “I am not taking my pill at lunch.”
QUESTION 12
A 14-year-old patient is prescribed Strattera and asks when the medicine should be
taken. What does the PMHNP understand regarding the drug’s dosing profile?
A. The patient should take the medication at lunch. B. The patient will have one or
two doses a day. C. The patient will take a pill every 17 hours. D. The dosing should be
done in the morning and at night.
QUESTION 13
The PMHNP is meeting with the parents of an 8-year-old patient who is receiving an
initial prescription for D-amphetamine. The PMHNP demonstrates appropriate
prescribing practices when she prescribes the following dose:
A. The child will be prescribed 2.5 mg. B. The child will be prescribed a 10-mg tablet. C.
The child’s dose will increase by 2.5 mg every other week. D. The child will take 10–40
mg, daily.
QUESTION 14 [Show Less]